AzTrials
AzTrials

SyncopeNCT02316860

The Diagnostic Performance of Tilt Test in Athletes

A study testing Passive tilt test in people with Syncope, run by Aristotle University Of Thessaloniki at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the present study the investigators evaluate the sensitivity and specificity of passive tilt test in athletes, as well as their haemodynamic responses and autonomic nervous system activity during head-up tilt. Read more about this study

Who is it for?
Ages 14 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Syncope
What is being tested?
Passive tilt test
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteGreece
Study dates
Oct 2014to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • 14-40 years old,
  • more than 5 years of exercise training experience and competition at a regional level at different sports

Who cannot join

  • smoking,
  • recent alcohol consumption,
  • presence of any chronic disease and use of drugs

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Laboratory of Sports Medicine, Sports Medicine Division, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Thessaloniki, 54622

Other trials in Greece

About this study

Official title: The Diagnostic Performance of Tilt Test in Athletes and a Novel Strategy for Its Improvement

In the present study the investigators evaluate the sensitivity and specificity of passive tilt test in athletes, as well as their haemodynamic responses and autonomic nervous system activity during head-up tilt. Moreover, the investigators try to apply a novel algorithm for the improvement of diagnostic yield of tilt test in athletes.

Read the detailed description

We examine athletes with a history of reflex syncope and athletes without history of reflex syncope.All subjects undergo a tilt test, for the evaluation of haemodynamics, heart rate variability (HRV) and baroreflex sensitivity.

Conditions
Syncope
Being tested
Passive tilt test
Medical subject headings
Syncope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Passive tilt testOther

    Passive tilt test (without pharmacological provocation). After a horizontal supine rest period of 5 min, the tilt table was inclined at 60° head-up position for 30 min. A positive response was defined according to the European Society of Cardiology guidelines for the diagnosis and management of syncope

Study groups in NCT02316860
Study groupRoleWhat they receive
History of reflex syncopeOtherPassive tilt test in athletes with a history of reflex syncope
Receives: Other: Passive tilt test
No history of reflex syncopeOtherPassive tilt test in athletes without history of reflex syncope
Receives: Other: Passive tilt test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. sensitivity and specificity of tilt test in athletes as measured by the occurence of syncope/presyncope during tilt test

    sensitivity = number of subjects with syncope/presyncope during tilt test/ number of subjects with a history of reflex syncope, specificity = number of subjects without syncope/presyncope during tilt test/ number of subjects without history of reflex syncope

    Measured: 30 min

Secondary outcomes (3)
  1. Parameters of haemodynamics during tilt test

    We investigate whether the mean values of parameters of haemodynamics during tilt test can discriminate between athletes with a history of reflex syncope and those without history of syncope

    Measured: 30 min

  2. Parameters of heart rate variability during tilt test

    We investigate whether the mean values of parameters of heart rate variability during tilt test can discriminate between athletes with a history of reflex syncope and those without history of syncope

    Measured: 30 min

  3. Parameters of baroreflex sensitivity during tilt test

    We investigate whether the mean values of parameters of baroreflex sensitivity during tilt test can discriminate between athletes with a history of reflex syncope and those without history of syncope

    Measured: 30 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionDec 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02316860
Sponsor's protocol ID
sportscardiology
Status last verified
Oct 2017
First submitted
6 Dec 2014
Last updated
26 Oct 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Passive tilt test in people with Syncope, run by Aristotle University Of Thessaloniki at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

sensitivity and specificity of tilt test in athletes as measured by the occurence of syncope/presyncope during tilt test (time frame: 30 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in